As the industry continues to externalize components of the supply chain, global regulatory authorities are requiring a “quality-by-design” (QbD) approach to help mitigate risk across the drug development process.
Microfluidics chose Interphex 2010 in New York, US to unveil a new processing technology that it claims can help manufacturers save time and money by switching from batch to continuous particle production.
Failure to get it right in designing and implementing a
manufacturing process results in the loss of time and money, but
the risk of this can be minimised if some basic organisational
steps are followed, argues Brookwood's director...
The GEA Group has acquired the manufacturer of freeze dryers for
pharmaceutical products, STERIS, a unit of US-based STERIS
Corporation in a deal that aims to strengthen the group's Process
Engineering Division in the Process...
The marriage between US chemicals group Dynamic Synthesis and
French separations specialist Novasep has been completed, creating
what the new company claims is a unique company to serve the life
GEA, a subsidiary of mg technologies, today announced that it has
acquired the business of Messo-Chemietechnik, which specialises in
crystallisation technologies for the biotechnology, pharmachem and
German processing technology group GEA has announced new
acquisitions that will increase its offering to the food and pharma
industries, part of a new strategy to expand the business under
parent company mg technologies.